During development and differentiation into functional plasma cells, B cells undergo two DNA recombination reactions, V(D)J and class switch recombination (CSR), and a process of extensive somatic hypermutation (SHM). The functional consequences of these three reactions result in the production of a mature immune system that is diverse, has high affinity for antigens, and exhibits a wide range of functions. Although all these reactions are beneficial to the generation of a fully functional immune system, they permanently modify the information encoded in the DNA, and any mistake could lead to immune deficiency and/or transformation. The Primary Immune Deficiency Program at Mount Sinai School of Medicine is currently treating a large population of patients with severe combined immune deficiency (SCID), combined immune deficiency (CID) and common variable immune deficiency (CVID). While there has been much progress in delineating the molecular causes of SCID, currently about 20% of all cases are still of unknown origin. In addition, the molecular defects present in patients with CID and CVID have not yet been defined. This application proposes to investigate the hypothesis that deregulation and/or mutations in factors that constitute the repair machinery of (Aim 1) V(D)J recombination and for (Aim 2) class switch recombination and somatic hypermutation represents some of the molecular defects responsible for SCID, and some patients with CID and CVID. This hypothesis will be investigated by using pre-established reporter systems. DNA sequence and biochemical activity of the repair factors will also be investigated. Results obtained from the proposed analysis will help to understand the molecular defects present in these patients and facilitate the path to finding better treatments for these life threatening diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI061093-04
Application #
7367086
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2007-03-01
Budget End
2008-02-29
Support Year
4
Fiscal Year
2007
Total Cost
$313,204
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Ho, Hsi-En; Byun, Minji; Cunningham-Rundles, Charlotte (2018) Disseminated Cutaneous Warts in X-Linked Hyper IgM Syndrome. J Clin Immunol 38:454-456
Schwab, Charlotte; Gabrysch, Annemarie; Olbrich, Peter et al. (2018) Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects. J Allergy Clin Immunol 142:1932-1946
Smith, Tukisa D; Cunningham-Rundles, Charlotte (2018) Detection of anti-glutamic acid decarboxylase antibodies in immunoglobulin products. J Allergy Clin Immunol Pract 6:260-261
Petersheim, Daniel; Massaad, Michel J; Lee, Saetbyul et al. (2018) Mechanisms of genotype-phenotype correlation in autosomal dominant anhidrotic ectodermal dysplasia with immune deficiency. J Allergy Clin Immunol 141:1060-1073.e3
Bucciol, Giorgia; Moens, Leen; Bosch, Barbara et al. (2018) Lessons learned from the study of human inborn errors of innate immunity. J Allergy Clin Immunol :
Shan, Meimei; Carrillo, Jorge; Yeste, Ada et al. (2018) Secreted IgD Amplifies Humoral T Helper 2 Cell Responses by Binding Basophils via Galectin-9 and CD44. Immunity 49:709-724.e8
Casanova, Jean-Laurent; Abel, Laurent (2018) Human genetics of infectious diseases: Unique insights into immunological redundancy. Semin Immunol 36:1-12
Gernez, Yael; Freeman, Alexandra F; Holland, Steven M et al. (2018) Autosomal Dominant Hyper-IgE Syndrome in the USIDNET Registry. J Allergy Clin Immunol Pract 6:996-1001
Feuille, Elizabeth J; Anooshiravani, Niloofar; Sullivan, Kathleen E et al. (2018) Autoimmune Cytopenias and Associated Conditions in CVID: a Report From the USIDNET Registry. J Clin Immunol 38:28-34
Barbet, Gaetan; Sander, Leif E; Geswell, Matthew et al. (2018) Sensing Microbial Viability through Bacterial RNA Augments T Follicular Helper Cell and Antibody Responses. Immunity 48:584-598.e5

Showing the most recent 10 out of 189 publications